Literature DB >> 16980718

The heart in dermatomyositis and polymyositis.

I E Lundberg1.   

Abstract

Cardiovascular manifestations constitute a major cause of death in myositis. Despite this, clinically manifest cardiac involvement in polymyositis and dermatomyositis is relatively rare. In contrast, subclinical manifestations are frequently reported and are predominated by conduction abnormalities and arrhythmias detected by ECG. The most frequently reported clinically overt manifestations are congestive heart failure, conduction abnormalities, that may lead to complete heart block, and coronary artery disease. The underlying pathophysiological mechanisms that may cause cardiac manifestations involve myocarditis and coronary artery disease as well as involvement of the small vessels of the myocardium.

Entities:  

Mesh:

Year:  2006        PMID: 16980718     DOI: 10.1093/rheumatology/kel311

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  43 in total

1.  Long-term follow-up of 62 patients with myositis.

Authors:  Janneke van de Vlekkert; Jessica E Hoogendijk; Marianne de Visser
Journal:  J Neurol       Date:  2014-05       Impact factor: 4.849

2.  Whole-body MRI in adult inflammatory myopathies: Do we need imaging of the trunk?

Authors:  Lukas Filli; Britta Maurer; Andrei Manoliu; Gustav Andreisek; Roman Guggenberger
Journal:  Eur Radiol       Date:  2015-04-24       Impact factor: 5.315

3.  Clinical status and cardiovascular risk profile of adults with a history of juvenile dermatomyositis.

Authors:  Micah J Eimer; Wendy J Brickman; Roopa Seshadri; Rosalind Ramsey-Goldman; David D McPherson; Beverly Smulevitz; Neil J Stone; Lauren M Pachman
Journal:  J Pediatr       Date:  2011-07-23       Impact factor: 4.406

Review 4.  Clinical features, pathogenesis and treatment of juvenile and adult dermatomyositis.

Authors:  Angela B Robinson; Ann M Reed
Journal:  Nat Rev Rheumatol       Date:  2011-09-27       Impact factor: 20.543

5.  Decreased flow-mediated dilatation with increased arterial stiffness and thickness as early signs of atherosclerosis in polymyositis and dermatomyositis patients.

Authors:  Melinda Vincze; H Dér; Gy Kerekes; P Szodoray; M Zeher; K Dankó; P Soltész
Journal:  Clin Rheumatol       Date:  2014-03-12       Impact factor: 2.980

6.  Cardiac function in patients with polymyositis or dermatomyositis: a three-dimensional speckle-tracking echocardiography study.

Authors:  Yue Zhong; Wenjuan Bai; Qibing Xie; Jianhong Sun; Hong Tang; Li Rao
Journal:  Int J Cardiovasc Imaging       Date:  2017-11-22       Impact factor: 2.357

7.  Dilated cardiomyopathy and inclusion body myositis.

Authors:  Piercarlo Ballo; Leandro Chiodi; Matteo Cameli; Alessandro Malandrini; Antonio Federico; Sergio Mondillo; Alfredo Zuppiroli
Journal:  Neurol Sci       Date:  2011-09-16       Impact factor: 3.307

8.  Pregnancy outcomes in adult patients with dermatomyositis and polymyositis.

Authors:  Kathleen D Kolstad; David Fiorentino; Shufeng Li; Eliza F Chakravarty; Lorinda Chung
Journal:  Semin Arthritis Rheum       Date:  2017-11-20       Impact factor: 5.532

Review 9.  Selected aspects of the current management of myositis.

Authors:  James Lilleker; Sean Murphy; Robert Cooper
Journal:  Ther Adv Musculoskelet Dis       Date:  2016-06-19       Impact factor: 5.346

10.  Brief report: antisynthetase syndrome-associated myocarditis.

Authors:  Kavita Sharma; Ana-Maria Orbai; Dipan Desai; Oscar H Cingolani; Marc K Halushka; Lisa Christopher-Stine; Andrew L Mammen; Katherine C Wu; Sammy Zakaria
Journal:  J Card Fail       Date:  2014-07-29       Impact factor: 5.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.